Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 25Sarcoma 6Thoracic 5Genitourinary 4Gastrointestinal 4Head & Neck 3Breast 2Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Mesothelioma 53Advanced Solid Tumors 53Solid Tumor 51Advanced Solid Tumor 41Mesothelioma, Malignant 38Solid Tumors 35Unspecified Adult Solid Tumor, Protocol Specific 27Carcinoma, Non-Small-Cell Lung 25Retinoblastoma 14Melanoma 14Esophageal Neoplasms 14Solid Tumor, Adult 13Sarcoma 12Ovarian Neoplasms 12Lung Neoplasms 11Carcinoma, Renal Cell 11Uterine Cervical Neoplasms 10Small Cell Lung Carcinoma 10Stomach Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Advanced Solid Tumours 7Neoplasms 6Urinary Bladder Neoplasms 5Thyroid Neoplasms 5Solitary Fibrous Tumor, Pleural 5Malignant Solid Tumor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uterine Neoplasms × Other solid neoplasm × Clear all
NCT01271959 2012-10-05

A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Precision Therapeutics

Terminated
167 enrolled
EndocrineGynecologicOther solid neoplasmSarcomaThoracic

Adenocarcinoma, Carcinoid Tumor, Mesothelioma, Recurrence, Sarcoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡